AGB1

N/A

Report date: 2023/03/21 15:17:22
NME

Base Information

Drug NameAGB1
Drug Alias NameAGB-1AGB1
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionBromodomain-containing protein 4 degraders
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Dundee
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Dundee
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A